Natalizumab Subcutaneous Immunogenicity and Safety Study
Clinical trial NCT02142192 · TERMINATED
Trial details
- NCT number
- NCT02142192
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-06-04
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.